ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.
Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed to include site visits, our application allows for continuous data collection in between visits to the clinic.
By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.
The result: robust data collection, increased compliance, faster recruitment and improved time to completion.
To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.
Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.
Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials.
Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed to include site visits, our application allows for continuous data collection in between visits to the clinic.
By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.
The result: robust data collection, increased compliance, faster recruitment and improved time to completion.
To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.
Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.
Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials.
Location: United States, Florida, Orlando
Employees: 11-50
Total raised: $48M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | SPRIM Vent... | sprim.com |
| - | SPRIM Glob... | sprim.net |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.07.2021 | - | $31M | - |
| 20.05.2020 | - | $17M | - |
Mentions in press and media 36
| Date | Title | Description |
| 11.02.2026 | ObvioGo Now Integrated with Oracle Life Sciences Clinical One Data Collection | Collaboration adds critical decentralized trial capabilities to the Oracle Life Sciences Clinical One Data Collection solution NEW YORK, Feb. 10, 2026 /PRNewswire/ — ObvioHealth and Oracle Health and Life Sciences today announced that Obvio... |
| 17.01.2025 | ObvioHealth Introduces ObvioGo 2.2: Transforming Study Management with AI-Driven Innovation | AI-Driven Enhancements in ObvioGo 2.2 Redefine Efficiency, Compliance, and Innovation in Clinical Trial Management NEW YORK, Jan. 14, 2025 /PRNewswire/ — ObvioHealth, a global leader in digital clinical trial solutions, today announced the ... |
| 16.10.2024 | ObvioHealth Welcomes Richard Watkins as Chief Revenue Officer at a Pivotal Moment of Transformation | Experienced Sales Leader to Drive Revenue Growth as ObvioHealth Transitions to Enterprise Solutions NEW YORK, Oct. 16, 2024 /PRNewswire/ — ObvioHealth, a global leader in digital clinical trial solutions, announces the appointment of Richar... |
| 10.10.2024 | ObvioHealth Announces the Appointment of Nicholas Campbell to Its Board of Directors | NEW YORK, Oct. 10, 2024 /PRNewswire/ — ObvioHealth, a leading digital health company revolutionizing clinical trial solutions, is pleased to announce the appointment of Nicholas Campbell to its Board of Directors. Nicholas brings over 20 ye... |
| 29.07.2024 | ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally | July 25, 2024 – (PRNewswire) – ObvioHealth, a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company offering liquid and tissue biopsy tests across the can... |
| 25.07.2024 | ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally | SINGAPORE, July 25, 2024 /PRNewswire/ -- ObvioHealth, a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company offering liquid and tissue biopsy tests acro... |
| 06.03.2024 | Digital Clinical Trials: Avoiding Pitfalls with Intelligent Study Design, Upcoming Webinar Hosted by Xtalks | www.obviohealth.com In this free webinar, learn how adaptive protocols can enable medical device sponsors to merge Phase II and Phase III objectives into a single trial, saving precious time and budget. Attendees will learn how to rigorousl... |
| 09.02.2024 | ObvioHealth and Oracle Life Sciences Expand Partnership Globally | To integrate diverse data in decentralized clinical trials and offer enhanced multi-site, multi-lingual integrations ObvioHealth, a global digital clinical trials company, and Oracle Life Sciences are expanding their partnership globally fo... |
| 07.11.2023 | Deals in brief: Entropica Labs secures Series A funding, FPT acquires Cardinal Peak, multiple China and India deals, and more | Entropica Labs secures USD 4.7 million in Series A round The Singapore-based quantum software company has secured USD 4.7 million in a Series A funding round led by Liftt and existing investor Wavemaker Partners. The round was joined by SEE... |
| 07.11.2023 | Healthtech firm ObvioHealth raises $15m in latest funding round | ObvioHealth, a US- and Singapore-based clinical trials provider, has raised $15 million in its latest funding round, according to filings with Singapore’s Accounting and Corporate Regulatory Authority (ACRA). |
Show more